Philadelphia Pharmaceuticals : Assembly Decision-(PHIL)-2024-03-04

PHILADELPHIA PHARMACEUTICALS

To: Jordan Securities Commission,	ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻻﺍ ﺔﺌﻴﻫ ﺓﺩﺎﺴﻟﺍ
Amman Stock Exchange	ﻥﺎﻤﻋ ﺔﺻﺭﻮﺑ ﺓﺩﺎﺴﻟﺍ
Company's Name: PHILADELPHIA PHARMACEUTICALS	ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ :ﺔﻛﺮﺸﻟﺍ ﻢﺳﺍ
Date: 04-03-2024 02:38:10 PM	PM 02:38:10 2024-03-04 :ﺦﻳﺭﺎﺘﻟﺍ
Subject: The Resolutions Of The General Assembly	ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺞﺋﺎﺘﻧ :ﻉﻮﺿﻮﻤﻟﺍ
Meeting
The Ordinary General Assembly Meeting of	ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ 14:00 ﻰﻠﻋ 2024-03-04 ﺔﻋﺎﺴﻟﺍ َﺪﻘُﻋ
PHILADELPHIA PHARMACEUTICALS was held on 14:00	ﺔﻠﻴﺳﻭ ﻲﻓ ﻚﻟﺫﻭ.ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ ﺔﻛﺮﺸﻟ ﺔﻳﺩﺎﻌﻟﺍ
On 04-03-2024 at Zoom Meeting, the shareholders	ﺭﻮﻀﺣ ﺔﺒﺴﻨﺑﻭ ﻡﻭﻭﺯ ﺞﻣﺎﻧﺮﺑ - ﻲﻧﻭﺮﺘﻜﻟﻻﺍﻭ ﻲﺋﺮﻤﻟﺍ ﻝﺎﺼﺗﻻﺍ
participation in the Assembly Meeting was 91.08%	%91.08
The following decisions were adopted at the Meeting:-	-:ﺔﻴﻟﺎﺘﻟﺍ ﺕﺍﺭﺍﺮﻘﻟﺍ ﺫﺎﺨﺗﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻝﻼﺧ ﻢﺗ
Subject: Approving the minutes of the previous year	ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ
Ordinary General Assembly Meeting	ﻖﺑﺎﺴﻟﺍ
Approving the minutes of the previous year Ordinary	ﻖﺑﺎﺴﻟﺍ ﻱﺩﺎﻌﻟﺍ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﻉﺎﻤﺘﺟﺍ ﺮﻀﺤﻣ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ
General Assembly Meeting which was held on 17-04-	2023-04-17 ﺦﻳﺭﺎﺘﺑ ﺪﻘﻌﻨﻤﻟﺍﻭ
2023
Subject: Approving The Report of the Board of Directors	ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ
on the activities of the Company, for the year ended on	ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ
specified date
Approving The Report of the Board of Directors on the	ﺔﻨﺴﻠﻟ ﺔﻛﺮﺸﻟﺍ ﻝﺎﻤﻋﺍ ﻦﻋ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ
activities of the Company, for the year ended on 31-12-	2023-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ
2023
Subject: Approving the Report of the Company's auditors	ﻦﻋ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ
on its financial statements	ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ
Approving the Report of the Company's auditors on its	ﺕﺎﻧﺎﻴﺒﻟﺍ ﻦﻋ ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﺮﻳﺮﻘﺗ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ
financial statements, for the year ended on 31-12-2023	2023-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ
Subject: Approving the Financial Statements for the year	ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ
ended on	ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ
Approving the Financial Statements for the year ended on	-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ ﺔﻴﻟﺎﻤﻟﺍ ﺕﺎﻧﺎﻴﺒﻟﺍ ﻰﻠﻋ ﺔﻗﺩﺎﺼﻤﻟﺍ
31-12-2023	2023-12
Subject: Approving of the Board of Director's proposal to	ﻊﻓﺪﻟﺎﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺡﺍﺮﺘﻗﺍ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ
pay

Approving of the Board of Director's proposal to pay 7%

ﻰﻠﻋ ﺡﺎﺑﺭﺃ ﻊﻳﺯﻮﺗ ﻥﺎﺸﺑ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺡﺮﺘﻘﻣ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ

Page 1 of 2

PHILADELPHIA PHARMACEUTICALS

as cash dividends to the shareholders and distributing 0%	ﻝﺎﻤﻟﺍ ﺱﺍﺭ ﻦﻣ 7% ﺔﻴﺴﻨﺑ ﺔﻳﺪﻘﻧ ﺡﺎﺑﺭﺍ ﻦﻋ ﺓﺭﺎﺒﻋ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ
as bonus shares	ﻝﺎﻤﻟﺍ ﺱﺍﺭ ﻦﻣ 0% ﺔﻴﺴﻨﺑ ﺔﻴﻧﺎﺠﻣ ﻢﻬﺳﺍ ﻊﻳﺯﻮﺗﻭ
Subject: Discharging the board's members from their	ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ :ﻉﻮﺿﻮﻤﻟﺍ
liabilities in respect of the financial year ended	ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ ﻢﻬﺗﺎﻓﺮﺼﺗ
Discharging the board's members from their liabilities in	ﻢﻬﺗﺎﻓﺮﺼﺗ ﻦﻋ ﺔﻴﻟﻭﺆﺴﻤﻟﺍ ﻦﻣ ﺓﺭﺍﺩﻻﺍ ﺲﻠﺠﻣ ﺀﺎﻀﻋﺃ ﺔﻣﺫ ﺀﺍﺮﺑﺍ
respect of the financial year ended 31-12-2023	2023-12-31 ﻲﻓ ﺔﻴﻬﺘﻨﻤﻟﺍ ﺔﻨﺴﻟﺍ ﻝﻼﺧ
Subject: Approving the appointment / reappointment of the	ﺕﺎﺑﺎﺴﺤﻟﺍ ﻲﻘﻗﺪﻣ ﻦﻴﻴﻌﺗ ﺓﺩﺎﻋﺇ / ﻦﻴﻴﻌﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ :ﻉﻮﺿﻮﻤﻟﺍ
auditors for the financial year and authorizing the board of	ﻢﻬﺑﺎﻌﺗﺃ ﺪﻳﺪﺤﺘﻟ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗﻭ ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ
directors to determine their fees
Approving the appointment/reappointment of the auditors	ﺓﺩﺎﺴﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻲﻘﻗﺪﻣ ﻦﻴﻴﻌﺗ ﺓﺩﺎﻋﺍ ﻭﺍ/ ﻦﻴﻴﻌﺗ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺍ
International Professional Bureau for the financial year 31-	ﺔﻛﺮﺸﻟﺍ ﺕﺎﺑﺎﺴﺣ ﻖﻴﻗﺪﺘﻟ International Professional Bureau
12-2024.And authorizing the board of directors to	ﺪﻳﺪﺤﺘﺑ ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺾﻳﻮﻔﺗ ﻭ 2024-12-31 ﺔﻴﻟﺎﻤﻟﺍ ﺔﻨﺴﻠﻟ
determine their fees	ﻢﻬﺑﺎﻌﺗﺍ
Subject: Any other matters which the General Assembly	ﻲﻓ ﺎﻬﺟﺍﺭﺩﻹ ﺔﻣﺎﻌﻟﺍ ﺔﻴﻌﻤﺠﻟﺍ ﺎﻬﺣﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﻱﺃ :ﻉﻮﺿﻮﻤﻟﺍ
proposes to include in the agenda	ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ
Any other matter which the General Assembly proposes to	ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺎﻬﺟﺍﺭﺩﺇ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﺡﺮﺘﻘﺗ ﻯﺮﺧﺃ ﺭﻮﻣﺃ ﻱﺃ
include in the agenda, and are within the work scope of the	ﻥﺃ ﻰﻠﻋ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻠﻟ ﻱﺩﺎﻌﻟﺍ ﻉﺎﻤﺘﺟﻻﺍ ﻝﺎﻤﻋﺃ ﻕﺎﻄﻧ ﻲﻓ ﻞﺧﺪﻳﻭ
General Assembly in its ordinary meetings, provided that	ﻦﻣ ﺩﺪﻋ ﺔﻘﻓﺍﻮﻤﺑ ﻝﺎﻤﻋﻷﺍ ﻝﻭﺪﺟ ﻲﻓ ﺡﺍﺮﺘﻗﻻﺍ ﺍﺬﻫ ﺝﺍﺭﺩﺃ ﻥﺮﺘﻘﻳ
such a proposal is approved by shareholders representing	ﻲﻓ ﺔﻠﺜﻤﻤﻟﺍ ﻢﻬﺳﻷﺍ ﻦﻣ (%10) ﻦﻋ ﻞﻘﻳ ﻻ ﺎﻣ ﻥﻮﻠﺜﻤﻳ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ
not less than 10% of the shares represented in the meeting	ﻉﺎﻤﺘﺟﻻﺍ
ﻯﺮﺧﺃ ﺕﺍﺭﺎﺴﻔﺳﺍ ﻭﺃ ﻞﺋﺎﺴﻣ ﺪﺟﻮﺗ ﻻ	ﻯﺮﺧﺃ ﺕﺍﺭﺎﺴﻔﺳﺍ ﻭﺃ ﻞﺋﺎﺴﻣ ﺪﺟﻮﺗ ﻻ
Please accept our sincere thanks and appreciation.	.ﻡﺍﺮﺘﺣﻻﺍ ﻖﺋﺎﻓ ﻝﻮﺒﻘﺑ ﺍﻮﻠﻀﻔﺗﻭ
Chairman of Board of Directors	ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺲﻴﺋﺭ
User Name: Belal Salameh	Belal Salameh :ﻡﺪﺨﺘﺴﻤﻟﺍ ﻢﺳﺍ

Page 2 of 2